Profil
Gegenwärtig ist Thomas Schfer Chief Scientific Officer & Executive VP bei der Chr. Hansen Holding A. Er ist auch im Vorstand des Bioinnovation Institute. In der Vergangenheit war er Head-Business Development bei Novozymes A. Er promovierte an der Freien Universitt Berlin.
Aktuelle Nachrichten zu Thomas Schäfer
Aktive Positionen von Thomas Schäfer
| Unternehmen | Position | Beginn |
|---|---|---|
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Direktor/Vorstandsmitglied | - |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas Schäfer
| Unternehmen | Position | Ende |
|---|---|---|
| CHRISTIAN HANSEN | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2022 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | - |
Ausbildung von Thomas Schäfer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Manufactures food cultures, enzymes and nutrition products | Consumer Non-Durables |
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Finance |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Health Technology |
















